Phase II trial of chemoradiotherapy with S‐1 plus cisplatin for unresectable locally advanced head and neck cancer ( JCOG 0706)

Author:

Tahara Makoto1,Kiyota Naomi2,Mizusawa Junki3,Nakamura Kenichi4,Hayashi Ryuichi5,Akimoto Tetsuo6,Hasegawa Yasuhisa7,Iwae Shigemichi8,Monden Nobuya9,Matsuura Kazuto10,Fujii Hirofumi11,Onozawa Yusuke12,Homma Akira13,Kubota Akira14,Fukuda Haruhiko3,Fujii Masato15

Affiliation:

1. Department of Head and Neck Medical Oncology National Cancer Center Hospital East, KashiwaJapan

2. Department of Medical Oncology and Hematology Kobe University Hospital KobeJapan

3. Japan Clinical Oncology Group Data Center National Cancer Center TokyoJapan

4. Japan Clinical Oncology Group Operations Office National Cancer Center TokyoJapan

5. Department of Head and Neck Surgery KashiwaJapan

6. Department of Radiation Oncology National Cancer Center Hospital EastKashiwaJapan

7. Department of Head and Neck Surgery Aichi Cancer Center NagoyaJapan

8. Department of Head and Neck Surgery Hyogo Cancer Center AkashiJapan

9. Department of Head and Neck Surgery Shikoku Cancer Center MatsuyamaJapan

10. Division of Head and Neck Surgery Miyagi Cancer Center NatoriJapan

11. Department of Clinical Oncology Jichi Medical University ShimotsukeJapan

12. Division of Clinical Oncology Shizuoka Cancer Center ShizuokaJapan

13. Department of Otolaryngology Hokkaido University Hospital SapporoJapan

14. Department of Head and Neck Surgery Kanagawa Cancer Center YokohamaJapan

15. Department of Otolaryngology National Hospital Organization Tokyo Medical CenterTokyo Japan

Funder

National Cancer Center

Ministry of Health, Labour and Welfare

Ministry of Health and Welfare

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Reference23 articles.

1. Estimates of the worldwide incidence of 25 major cancers in 1990

2. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis

3. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

4. Antitumor activity of 1 M tegafur‐0.4 M 5‐chloro‐2,4‐dihydroxypyridine‐1 M potassium oxonate (S‐1) against human colon carcinoma orthotopically implanted into nude rats;Shirasaka T;Cancer Res,1996

5. [Late phase II study of S‐1 in patients with advanced head and neck cancer];Inuyama Y;Gan To Kagaku Ryoho,2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3